Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 1.000 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.658 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.610 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.577 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.534 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.513 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.503 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.503 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.500 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.497 | |
| 5cnn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.478 | |
| 4z61 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.472 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.469 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.467 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.467 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.463 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.463 | |
| 3vt5 | YI2 | Vitamin D3 receptor | / | 0.459 | |
| 4a6c | QG9 | Gag-Pol polyprotein | 3.4.23.16 | 0.459 | |
| 3w0a | DS5 | Vitamin D3 receptor | / | 0.454 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.453 | |
| 4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.453 | |
| 1yb5 | NAP | Quinone oxidoreductase | 1.6.5.5 | 0.452 | |
| 2q5g | 1FA | Peroxisome proliferator-activated receptor delta | / | 0.452 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.449 | |
| 3tqh | NDP | Quinone oxidoreductase | / | 0.449 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.448 | |
| 3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
| 1mg5 | NAI | Alcohol dehydrogenase | 1.1.1.1 | 0.447 | |
| 3rj9 | NAD | Alcohol dehydrogenase | 1.1.1.1 | 0.446 | |
| 3ogq | AB1 | Pol polyprotein | / | 0.445 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.443 | |
| 4a6b | QG8 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
| 1vik | BAY | Gag-Pol polyprotein | / | 0.442 | |
| 3vt3 | VDX | Vitamin D3 receptor | / | 0.442 | |
| 4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.442 | |
| 5jla | NAD | Putative short-chain dehydrogenase/reductase | / | 0.442 | |
| 3gw9 | VNI | Lanosterol 14-alpha-demethylase | / | 0.441 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
| 1iyz | NDP | Probable quinone oxidoreductase | / | 0.440 | |
| 1u3d | FAD | Cryptochrome-1 | / | 0.440 |